Boise, ID4 Active Studies

Pulmonary Hypertension Clinical Trials in Boise, ID

Find 4 actively recruiting pulmonary hypertension clinical trials in Boise, ID. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
817
Enrolling

Recruiting Pulmonary Hypertension Studies in Boise

RecruitingBoise, IDNCT06963827

A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition

Immunoglobulin A nephropathy (IgAN) is a kidney condition. It happens when the body's immune system creates groups of proteins (called immune complexes) that build-up in the kidneys causing swelling (...

347 participants
Takeda
View Study Details
RecruitingBoise, IDNCT05963074

A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic Leukemia

The purpose of this study is to evaluate the efficacy and safety of ibrutinib + venetoclax (I+V) and ibrutinib monotherapy regimens in which dosing of ibrutinib is either proactively reduced or reacti...

320 participants
Janssen Research & Development, LLC
View Study Details
RecruitingBoise, IDNCT06806033

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

The main goal of this trial is to study the frequency and severity of cytokine release syndrome (CRS) in participants with diffuse large B-cell lymphoma (DLBCL) who are using a combination of glofitam...

100 participants
Hoffmann-La Roche
View Study Details
RecruitingBoise, IDNCT05904080

Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer

This phase II trial tests how well nivolumab and ipilimumab immunotherapy with or without cabozantinib works in treating patients with nasopharyngeal cancer that has come back (after a period of impro...

50 participants
National Cancer Institute (NCI)
View Study Details

About Pulmonary Hypertension Clinical Trials in Boise

Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.

There are currently 4 pulmonary hypertension clinical trials recruiting participants in Boise, ID. These studies are seeking a combined 817 participants. Research is being sponsored by Takeda, Janssen Research & Development, LLC, Hoffmann-La Roche and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Hypertension Clinical Trials in Boise — FAQ

Are there pulmonary hypertension clinical trials in Boise?

Yes, there are 4 pulmonary hypertension clinical trials currently recruiting in Boise, ID. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Boise?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Boise research site will contact you about next steps.

Are clinical trials in Boise free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Boise studies also compensate for your time and travel.

What pulmonary hypertension treatments are being tested?

The 4 active trials in Boise are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.

Data updated March 2, 2026 from ClinicalTrials.gov